This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

Find out moreĀ here.

Open-label study of Denosumab in Subjects with Giant Cell Tumor

  • Research type

    Research Study

  • Full title

    An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects with Giant Cell Tumor of Bone

  • IRAS ID

    5481

  • Contact name

    Michael Parry

  • Contact email

    michael.parry3@nhs.net

  • Sponsor organisation

    Mount Vernon Hospital

  • Eudract number

    2008-001606-16

  • ISRCTN Number

    N/A

  • Clinicaltrials.gov Identifier

    NCT00680992

  • Research summary

    N/A

  • REC name

    Yorkshire & The Humber - Leeds West Research Ethics Committee

  • REC reference

    09/H1307/54

  • Date of REC Opinion

    14 Sep 2009

  • REC opinion

    Further Information Favourable Opinion